首页> 外国专利> PHARMACEUTICAL COMPOSITION COMPRISING OF REMOGLIFLOZIN OR SALT OR ESTER THEREOF AND VILDAGLIPTIN OR SALT THEREOF

PHARMACEUTICAL COMPOSITION COMPRISING OF REMOGLIFLOZIN OR SALT OR ESTER THEREOF AND VILDAGLIPTIN OR SALT THEREOF

机译:包含雷莫列净或其盐或酯和维格列汀或其盐的药物组合物

摘要

The invention relates to a stable pharmaceutical composition comprising remogliflozin or salt or ester thereof, and vildagliptin or salt thereof. In particular disclosed is a pharmaceutical composition comprising a first portion and a second portion, wherein said first portion comprises granules of remogliflozin or salt or ester thereof and a pharmaceutically acceptable excipient, said second portion comprises granules of vildagliptin or salt thereof and a pharmaceutically acceptable excipient; wherein granules of remogliflozin or salt or ester thereof are preapred by wet granulation and granules of vildagliptin or salt thereof are prepared by roller compaction; wherein said portions are compressed together to obtain a bilayer tablet dosage form which is coated with non-aquous seal coat.
机译:本发明涉及一种稳定的药物组合物,其包含雷莫列净或其盐或酯,以及维格列汀或其盐。特别公开的是包含第一部分和第二部分的药物组合物,其中所述第一部分包括雷莫列净或其盐或酯的颗粒和药学上可接受的赋形剂,所述第二部分包括维格列汀或其盐和药学上可接受的赋形剂的颗粒;其中,莫格列净或其盐或酯的颗粒是通过湿法制粒制备的,维格列汀或其盐的颗粒是通过辊压制备的;其中将所述部分压缩在一起以获得双层片剂剂型,所述双层片剂剂型用非水密封包衣包衣。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号